Antigen delivery and immune programming are the primary hurdles for H. pylori vaccine development
Vaccine Development Faces Challenges for H. pylori Infections
This narrative review examines the current landscape of H. pylori vaccine development for conditions like gastritis and gastric cancer. The …
New research identifies why H. pylori vaccines have struggled to move from laboratory success to clinical protection for patients with stoma…
Cocaine use is associated with higher mortality and surgical rates in ischemic colitis cases
Cocaine Use Linked to Severe Gastrointestinal Complications and Mortality
This narrative review examines gastrointestinal complications in patients with cocaine use. The review finds that cocaine-associated ischemi…
Cocaine use is linked to severe gastrointestinal issues, including higher mortality rates in cases of ischemic colitis compared to non-cocai…
Bismuth quadruple and concomitant regimens achieve >85% H. pylori eradication amid rising clarithromycin resistance
H. pylori treatments failing as resistance grows, review finds
This narrative review synthesizes current H. pylori eradication strategies, noting that clarithromycin resistance exceeds 15%-20% in most re…
Clarithromycin resistance now tops 15-20% in most regions, but bismuth quadruple and other combos still clear the bug over 85% of the time.
H. pylori eradication reduces gastric cancer risk by up to 44%, per guideline review
Review finds H. pylori eradication reduces risk of stomach cancer and ulcers
A narrative review of global evidence indicates H.
Treating a common stomach bacteria infection can lower future cancer risk by up to 44% and prevent recurring ulcers.
Questions about Peptic Ulcer
Does clarithromycin resistance affect how doctors treat a Peptic Ulcer infection?
Yes. When clarithromycin resistance is common, doctors often switch away from standard triple therapy to regimens like bismuth quadruple or concomitant therapy that still work well.
Full answer →Is bismuth quadruple therapy effective for treating H. pylori in Peptic Ulcer cases?
Yes. Bismuth quadruple therapy is a recommended first-line treatment for H. pylori in peptic ulcer disease, with eradication rates above 85% in most studies.
Full answer →